No Added Benefit of Nonsteroidal Anti-Inflammatory Drug Prophylaxis Beyond 15 Days for Heterotopic Ossification After Hip Arthroscopy
Muge Kirac, Tahir Koray Yozgatlı, Rauf Alizada, Enis Yildirim, Gokhan Polat, Asim Kayaalp, Baris Kocaoglu · 2026
Read No Added Benefit of Nonsteroidal Anti-Inflammatory Drug Prophylaxis Beyond 15 Days for Heterotopic Ossification After Hip Arthroscopy by Muge Kirac, Tahir Koray Yozgatlı, Rauf Alizada, Enis Yildirim, Gokhan Polat, Asim Kayaalp, Baris Kocaoglu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13546430.txt.
Description
Muge Kirac and co-authors compare drug regimens meant to stop unwanted bone growth after hip surgery in a 2026 study. After hip arthroscopy, some patients grow bone in soft tissue, which causes pain and stiffness and can force repeat surgery. Anti-inflammatory drugs are given to prevent it, but the best drug and course length were unsettled.
The multicenter study covered more than a thousand patients treated for hip impingement. Groups received one of two drugs for fifteen, thirty, or forty-five days. Rates of unwanted bone growth did not differ between groups, and nearly all patients stayed free of it. Longer courses did not lower the rate further, though pain and function scores varied by regimen. The authors conclude that fifteen days of prevention is enough for most patients.
Catalog record
| CREATOR | Muge Kirac, Tahir Koray Yozgatlı, Rauf Alizada, Enis Yildirim, Gokhan Polat, Asim Kayaalp, Baris Kocaoglu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 26 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |